Cdc25A Polyclonal Antibody

CDC25A (cell division cycle 25A) is a member of the CDC25 family of phosphatases. CDC25A is required for progression from G1 to the S phase of the cell cycle. It activates the cyclin-dependent kinase CDC2 by removing two phosphate groups. CDC25A is specifically degraded in response to DNA damage, which prevents cells with chromosomal abnormalities from progressing through cell division. CDC25A is an oncogene, although its exact role in oncogenesis has not been demonstrated. Two transcript variants encoding different isoforms have been found for this gene.

The Cdc25A Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of Cdc25A protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and sensitivity towards the target protein.

Cdc25A is a key regulator of cell cycle progression, playing a crucial role in the transition from G1 to S phase. Dysregulation of Cdc25A has been implicated in numerous pathological conditions, including cancer. Therefore, the accurate measurement of Cdc25A protein levels is of utmost importance in understanding its functional significance and potential therapeutic implications.

The Cdc25A Polyclonal Antibody exhibits exceptional performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been extensively validated for its specificity and minimal cross-reactivity with other related proteins, ensuring reliable and reproducible results.

This antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size, allowing for multiple experiments without compromising its quality. The Cdc25A Polyclonal Antibody is manufactured under strict quality control standards, guaranteeing batch-to-batch consistency and optimal performance.

In summary, the Cdc25A Polyclonal Antibody is a valuable tool for researchers and scientists involved in cell cycle studies, cancer research, and drug discovery. Its high specificity, sensitivity, and versatility make it an indispensable asset in elucidating the role of Cdc25A in various biological processes and disease mechanisms.